Prebet T - Search Results

1

Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial.

Watts JM, Baer MR, Yang J, Prebet T, Lee S, Schiller GJ, Dinner SN, Pigneux A, Montesinos P, Wang ES, Seiter KP, Wei AH, De Botton S, Arnan M, Donnellan W, Schwarer AP, Récher C, Jonas BA, Ferrell PB Jr, Marzac C, Kelly P, Sweeney J, Forsyth S, Guichard SM, Brevard J, Henrick P, Mohamed H, Cortes JE. Watts JM, et al. Among authors: prebet t. Lancet Haematol. 2023 Jan;10(1):e46-e58. doi: 10.1016/S2352-3026(22)00292-7. Epub 2022 Nov 10. Lancet Haematol. 2023. PMID: 36370742 Clinical Trial.

2

Secondary Philadelphia chromosome after non-myeloablative peripheral blood stem cell transplantation for a myelodysplastic syndrome in transformation.

Prebet T, Michallet AS, Charrin C, Hayette S, Magaud JP, Thiébaut A, Michallet M, Nicolini FE. Prebet T, et al. Bone Marrow Transplant. 2004 Jan;33(2):247-9. doi: 10.1038/sj.bmt.1704308. Bone Marrow Transplant. 2004. PMID: 14716291 No abstract available.

3

Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Michallet M, Le QH, Mohty M, Prébet T, Nicolini F, Boiron JM, Esperou H, Attal M, Milpied N, Lioure B, Bordigoni P, Yakoub-Agha I, Bourhis JH, Rio B, Deconinck E, Renaud M, Chir Z, Blaise D. Michallet M, et al. Among authors: prebet t. Exp Hematol. 2008 May;36(5):535-44. doi: 10.1016/j.exphem.2008.01.017. Epub 2008 Mar 17. Exp Hematol. 2008. PMID: 18346838 Free article.

4

Mobilization of autologous hematopoietic progenitors and subsequent transplantation is a safe and feasible procedure in chronic phase chronic myelogenous leukemia patients with cytogenetic resistance to imatinib.

Prebet T, Tigaud I, Hayette S, Clapisson G, Philip I, Michallet M, Nicolini FE. Prebet T, et al. Haematologica. 2005 Nov;90 Suppl:ECR36. Haematologica. 2005. PMID: 16266927 No abstract available.

5

A simplified, 96-well-adapted, ATP luminescence-based motility assay.

Restouin A, Aresta S, Prébet T, Borg JP, Badache A, Collette Y. Restouin A, et al. Among authors: prebet t. Biotechniques. 2009 Oct;47(4):871-5. doi: 10.2144/000113250. Biotechniques. 2009. PMID: 19852771 Free article.

6

Presence of a minor Philadelphia-positive clone in young adults with de novo T-cell ALL.

Prebet T, Mozziconacci MJ, Sainty D, Arnoulet C, Lafage M, Dastugue N, Charbonnier A, Coso D, Gastaut JA, Blaise D, Vey N. Prebet T, et al. Leuk Lymphoma. 2009 Mar;50(3):485-7. doi: 10.1080/10428190802601148. Leuk Lymphoma. 2009. PMID: 19197723 No abstract available.

7

Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation.

Chevallier P, Prebet T, Turlure P, Hunault M, Vigouroux S, Harousseau JL, Blaise D, Ifrah N, Milpied N, Mohty M. Chevallier P, et al. Among authors: prebet t. Bone Marrow Transplant. 2010 Jan;45(1):165-70. doi: 10.1038/bmt.2009.153. Epub 2009 Jul 6. Bone Marrow Transplant. 2010. PMID: 19584826

8

Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation.

Prébet T, Ladaique P, Ferrando M, Chabannon C, Faucher C, De Lavallade H, El-Cheikh J, Furst S, Vey N, Stoppa AM, Viens P, Blaise D, Mohty M. Prébet T, et al. Exp Hematol. 2010 Jan;38(1):55-60. doi: 10.1016/j.exphem.2009.10.004. Exp Hematol. 2010. PMID: 19837124 Free article.

9

Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

Santini V, Schemenau J, Levis A, Balleari E, Sapena R, Adès L, Guerci A, Beyne-Rauzy O, Gourin MP, Cheze S, Stamatoullas A, Sanna A, Gioia D, Cametti G, Ferrero D, Raffoux E, Rose C, Poloni A, Prebet T, Legros L, Natarajan-Amé S, Fenaux P, Germing U, Dreyfus F, Park S. Santini V, et al. Among authors: prebet t. Blood. 2013 Sep 26;122(13):2286-8. doi: 10.1182/blood-2013-07-512442. Blood. 2013. PMID: 24072851 Free article. No abstract available.

10

Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations.

Santini V, Prebet T, Fenaux P, Gattermann N, Nilsson L, Pfeilstöcker M, Vyas P, List AF. Santini V, et al. Among authors: prebet t. Leuk Res. 2014 Dec;38(12):1381-91. doi: 10.1016/j.leukres.2014.09.008. Epub 2014 Sep 22. Leuk Res. 2014. PMID: 25444075 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page